REG - Vulcan Two Group PLC - Lease Signed for New Distribution Centre

Vulcan TwoAnnouncement

Today 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260305:nRSE3972Va&default-theme=true

RNS Number : 3972V  Vulcan Two Group PLC  05 March 2026

 

5 March 2026

Vulcan Two Group plc

(the "Group" or "Vulcan Two")

 

Lease signed for new distribution centre

 

Vulcan Two Group plc, the company aiming to create the UK's leading regulated
ePharmacy through buy-and-build, announces that it has entered into a
long-term lease agreement for a new 22,000 sq ft distribution centre in Leeds.

 

The lease agreement follows the announcement on 26 February 2026 that the
Group has conditionally raised £40 million through an institutional placing
to acquire three companies in the ePharmacy sector. As detailed in that
announcement and in the Admission Document published on 27 February 2026, the
Directors believe that establishing a central warehouse facility will enable
the Group to reduce warehousing and logistical costs, rationalise and simplify
processes, improve carrier terms and significantly enhance service and
delivery times. The Directors see this as a key pillar in the creation of a
scalable platform that can support the Group's growth going forward.

 

Under the terms of the lease, the Group will pay rent of approximately
£68,000 for the first 8 months of the lease and rent of approximately
£200,000 per annum thereafter. The lease agreement is for a term of ten
years, with a rent review and a break at the option of the Group after five
years.

 

Michael Kraftman, Chief Executive Officer of Vulcan Two, commented: "This new
distribution centre is an important piece of the jigsaw for Vulcan Two.
Situated in Leeds and well connected to the M62 and M1, the centre creates the
perfect platform for the efficient delivery of medications around the country.
We look forward to building this facility out and establishing a
market-leading service for patients."

 

For further information please contact:

 

 Vulcan Two Group plc                                    Email: info@vulcantwo.com (mailto:info@vulcantwo.com)

 Michael Kraftman, Chief Executive Officer

 Brendan O'Brien, Chief Operating Officer

 www.vulcantwo.com (http://www.vulcantwo.com)
 Canaccord Genuity Limited                               Tel: +44 (0) 20 7523 8000

(Nominated Adviser and Sole Broker)

 Simon Bridges / Harry Pardoe / Elizabeth Halley-Stott
 Alma Strategic Communications                           Email: vulcantwo@almastrategic.com (mailto:vulcantwo@almastrategic.com)

(Financial PR)

                                                       Tel: +44 (0) 20 3405 0205
 Justine James / Sam Modlin / Will Merison

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCJIMMTMTTMTTF



            Copyright 2019 Regulatory News Service, all rights reserved